EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025

Toralf Reimer, Thorsten Kuehn, Volkmar Mueller, Nina Ditsch, Tanja Fehm, Ute-Susann Albert, Rupert Bartsch, Ingo Bauerfeind, Vesna Bjelic-Radisic, Jens-Uwe Blohmer, Wilfried Budach, Peter Dall und 38 weitere

European Journal of Surgical Oncology · 2025-11 · 51 (11) · 110445

DOI: 10.1016/j.ejso.2025.110445 ↗

Kurz gefasst

Leitlinie in der Zeitschrift European Journal of Surgical Oncology, 2025-11. Verfasst von Toralf Reimer und 49 weiteren Autor:innen. Beteiligte Einrichtung: Universitätsfrauenklinik und Poliklinik Am Klinikum Südstadt, Rostock, Germany. Electronic address: toralf.reimer@med.uni-rostock.de. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The German Guideline Commission (AGO: Working Group on Gynecologic Cancers) updated its recommendations on the diagnosis and treatment of breast cancer in March 2025. Chapters on oncological and oncoplastic-reconstructive surgery are coordinated with the Working Group for Plastic, Aesthetic, and Reconstructive Surgery in Gynecology (AWOgyn). The most important changes include the incorporation of INSEMA and SOUND trial results into the guidelines. In patients with low-risk characteristics, defined as age ≥50 years, postmenopausal status, hormone receptor-positive/HER2-negative subtype, tumor grading G1-2 with a maximum preoperative size of 2 cm, and unsuspicious axillary ultrasound and clinical examination, the sentinel lymph node biopsy (SLNB) can be omitted if breast-conserving surgery and whole-breast irradiation are planned. In patients with 1-2 macrometastatic sentinel lymph nodes (SLNs) undergoing a mastectomy and postoperative irradiation, completion axillary lymph node dissection (ALND) is no longer recommended. After neoadjuvant systemic therapy (NST), ALND is recommended if the targeted axillary dissection (TAD) shows macrometastases in the sentinel and/or in the target lymph node (the node that was marked and had a macrometastasis in the biopsy before NST). Patients with isolated tumor cells in the sentinel and/or target lymph node should not receive ALND after NST. In case of ypN1mi status, the decision to perform a completion ALND should be made on a case-by-case basis. Oncoplastic surgery is safe and may replace a mastectomy in select cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansAxillaLymph Node ExcisionLymphatic MetastasisMastectomyMastectomy, SegmentalNeoadjuvant TherapyNeoplasm StagingSentinel Lymph Node Biopsy

Stichwörter der Autor:innen

Axillary surgeryBreast cancerBreast surgeryGuidelinesOncoplastic breast surgery

Autor:innen und Institutionen

  • Universitätsfrauenklinik und Poliklinik Am Klinikum Südstadt, Rostock, Germany. Electronic address: toralf.reimer@med.uni-rostock.de.
  • Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm, Germany; Filderklinik, Filderstadt, Germany.
  • Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Gynecology, Obstetrics and Senology, Faculty of Medicine, University of Augsburg, Breast Center, University Hospital Augsburg, CCC Alliance WERA, Augsburg, Germany.
  • Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Düsseldorf, Germany.
  • Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Würzburg, Germany.

Zitieren

APA

Reimer, T., Kuehn, T., Mueller, V., Ditsch, N., Fehm, T., Albert, U. S., Bartsch, R., Bauerfeind, I., Bjelic-Radisic, V., Blohmer, J. U., Budach, W., Dall, P., Fallenberg, E. M., Fasching, P. A., Friedrich, M., Gerber, B., Gluz, O., Harbeck, N., Hartkopf, A., …, & Thill, M. (2025). AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025. European Journal of Surgical Oncology, 51(11), 110445. https://doi.org/10.1016/j.ejso.2025.110445

Vancouver

Reimer T, Kuehn T, Mueller V, Ditsch N, Fehm T, Albert US, et al. AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025. European Journal of Surgical Oncology. 2025;51(11):110445. doi:10.1016/j.ejso.2025.110445

BibTeX
@article{Reimer2025,
  author = {Reimer, Toralf and Kuehn, Thorsten and Mueller, Volkmar and Ditsch, Nina and Fehm, Tanja and Albert, Ute-Susann and Bartsch, Rupert and Bauerfeind, Ingo and Bjelic-Radisic, Vesna and Blohmer, Jens-Uwe and Budach, Wilfried and Dall, Peter and Fallenberg, Eva Maria and Fasching, Peter A and Friedrich, Michael and Gerber, Bernd and Gluz, Oleg and Harbeck, Nadia and Hartkopf, Andreas and Heil, Joerg and Hoerner-Rieber, Juliane and Huober, Jens and Janni, Wolfgang and Kreipe, Hans-Heinrich and Krug, David and Kuemmel, Sherko and Loibl, Sibylle and Lueftner, Diana and Lux, Michael Patrick and Maass, Nicolai and Mundhenke, Christoph and Park-Simon, Tjoung-Won and Reinisch, Mattea and Rhiem, Kerstin and Rody, Achim and Schmidt, Marcus and Schneeweiss, Andreas and Schuetz, Florian and Sinn, Hans-Peter and Solbach, Christine and Solomayer, Erich-Franz and Stickeler, Elmar and Thomssen, Christoph and Untch, Michael and van Mackelenbergh, Marion and Witzel, Isabell and Woeckel, Achim and Wuerstlein, Rachel and Banys-Paluchowski, Maggie and Thill, Marc},
  title = {AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  volume = {51},
  number = {11},
  pages = {110445},
  doi = {10.1016/j.ejso.2025.110445}
}
Kostenlos starten →